1. Healthcare

1
PRELIMINARY PROGRAM (SUBJECT TO CHANGES)
AS OF DECEMBER 8, 2014
WEDNESDAY February 18, 2015
10:00
Registration starts
Hall I
15:0016:30
16:4518:15
18:30
18:30
18:3519:00
Hall II
Hall III
Hall IV
Parallel Industry Workshop
Parallel Industry Workshop
Parallel Industry Workshop
Parallel Industry Workshop
Parallel Industry Workshop
Parallel Industry Workshop
OPENING CEREMONY (Hall I)
Opening remarks – Tadej Battelino
Keynote speaker – Yves Reznik – CSII in type 2 diabetes: evolution or revolution?
Networking Reception (Exhibition Area)
2
THURSDAY FEBRUARY 19, 2015
08:30-10:00
10:00-10:30
10:30-12:00
12:00-13:00
Hall I
SESSION 1 – PLENARY
TECHNOLOGIES AND TYPE 2
DIABETES
Paolo Pozzilli – The impact of
new technology in type 2
diabetes
Walter Pories – Late
complications of bariatric
surgery
Bruce Bode – Treatment of
type 2 diabetes: what are the
best options?
COFFEE BREAK
Hall III
Hall IV
SESSION 4 – PARALLEL
GLUCOSE CONTROL IN THE
ICU
James Krinsley Diabetics are different - diabetic
status and the relationship of the
3 domains of glycemic control to
mortality in the critically ill
Jean Charles Preiser reporting of glucose control
metrics
Gosia Wilinska - “Glucose
control in the ICU using
continuous glucose monitoring:
What level of measurement error
is acceptable?”
Martin Haluzik Perioperative glucose control in
cardiac surgery patients: another
SESSION 5 – Parallel
Industry Workshop
Session 2 – PLENARY
INDUSTRY SYMPOSIUM
LUNCH & TECH FAIR (Exhibition Area)
SESSION 3 – PARALLEL
CHALLENGES IN DIABETES
13:00-14:30
Hall II
Jay Skyler – Immune
interventions in type 1 diabetes
2015
Mark Sperling – Continuous
glucose monitoring for diagnosis
and management of childhood
hypoglycemia
Katharine Barnard –
Psychological measures used in
diabetes technologies research
PARALLEL ORAL
PRESENTATIONS
3
possibility to improve the
outcomes?
14:30-15:00
15:00-16:30
16:30-18:00
COFFEE BREAK
SESSION
6
–
PLENARY
INDUSTRY SYMPOSIUM
SESSION 9 - WORKSHOPSESSION 8 – PARALLEL
PSYCHOSOCIAL ASPECTS
INDUSTRY SYMPOSIUMRELATING TO THE USE OF
THE ARTIFICIAL PANCREAS
The workshop will highlight the
importance and added value of
psychosocial assessment in AP
clinical trials
Facilitators:
Katharine Barnard
Lori Laffel
Korey Hood
Jill Weissberg-Benchel
Lutz Heinemann
Thomas Kubiak
SESSION 7 – PARALLEL
INDUSTRY SYMPOSIUM
Session 10 - PARALLEL
INDUSTRY WORKSHOP
4
FRIDAY FEBRUARY 20, 2015
Hall I
Hall II
Hall III
Hall IV
SESSION 11 - PLENARY – CLOSING THE LOOP – HOME STUDIES
08:30-10:00
10:00-10:30
10:30-12:00
12:00-13:00
13:00-14:30
14:30-15:00
Roman Hovorka – Update on home closed loop studies and factors affecting
outcomes
Eyal Dassau - Day-to-day challenges of glucose control and the artificial
pancreas beyond overnight and meal glucose control
Moshe Phillip/Tadej Battelino/Thomas Danne – the DREAM project
COFFEE BREAK
Session 12 – PLENARY INDUSTRY SYMPOSIUM
LUNCH & TECH FAIR (Exhibition Area)
SESSION 13 – PLENARY – YEARBOOK
Chairmen: Moshe Phillip and Tadej Battelino
Satish Garg/Irl Hirsch - Self Blood Glucose Monitoring
Satish Garg - New Medications for the Treatment of Diabetes
Bruce Bode/Tadej Battelino - Continuous Glucose Monitoring
Eyal Dassau/Eran Atlas - Closing the Loop
Jan Bolinder/Thomas Danne - New Insulins and Insulin Therapy
Lutz Heinemann - Insulin Pens and New Ways of Insulin Delivery
Neal Kaufman - Using Health Information Technology to Prevent and Treat
Diabetes
Moshe Hod/ Lois Jovanovič - Technology use in Diabetes and Pregnancy
Walter Pories - Bariatric Surgery and Diabetes
Jay Skyler - Type 1 Diabetes Mellitus: Immune Intervention
Michael Riddell - Advances in Exercise Physical Activity and Diabetes Mellitus
Shlomit Shalitin/ Peter Chase - Diabetes Technology and Treatment in the
Pediatric Age Group
Bruce Buckingham/Moshe Phillip/Alon Liberman - Diabetes Technology
and the Human Factor
COFFEE BREAK
PARALLEL INDUSTRY
SYMPOSIUM
5
15:00-16:30
16:30-17:30
SESSION 14 – PARALLEL
CLINICAL PRACTICE IN
TREATING ADULT PATIENTS
WITH DIABETES
Chairperson: Irl Hirsch and
Irl Hirsch - Individualizing
treatment targets for adult
patients with type 1 diabetes
Robert Gabbay Individualizing treatment
targets for adult patients with
type 2 diabetes
Randie Little - Clinical use of
Point of Care (POC) HbA1c
testing
SESSION 18 – PARALLEL
ORAL PRESENTATIONS
SESSION 20 – PARALLEL
CLINICAL PRACTICE IN
TREATMENT OF DIABETES IN
THE PEDIATRIC AGE GROUP
Peter Chase – Hypoglycemia
Reduction with Closed-Loop
Systems by Age
Thomas Danne – Patch pumps
vs. durable pumps in children
with type 1 diabetes
Lori Laffel – approaches to
behavioral interventions to
encourage CGM use in pediatric
patients
Andrea Scaramuzza – fine
tuning of insulin therapy in
children using insulin pumps
SESSION 21 – PARALLEL
ORAL PRESENTATIONS
SESSION 15 – PARALLEL
IMPACT OF NEW TECHNOLOGIES
ON THE HEALTH CARE SYSTEM
SESSION 17 – PARALLEL
EU AND DIABETES
Chairpersons: Eric Renard
and Hans de Vries
Martin van der Graaf - new
diabetes drugs: value for money or
money for value?
Wiebke Löbker – Market Access of
antidiabetics in Germany:
Assessment of antidiabetics by the
Federal Joint Committee (G-BA)
SESSION 16 - PARALLEL
TBC
Lutz Heinemann AP@home and AP4LIFE:
Status and Outlook
Peter Diem - GOCarb
Eric Renard - DIADVISOR,
Michael Mark - Micro- and
Marcrovascular
complications of diabetes contributions from the IMI
consortium SUMMIT
SESSION 19 – PARALLEL
PREGNANCY AND DIABETES
SESSION 22 – PARALLEL
INDUSTRY WORKSHOP
Moshe Hod - FIGO GDM Initiative
Project – Implementing the
Diagnosis of GDM in the Low Income
Countries
Yariv Yogev - What should be the
glycemic goals in pregnancy
complicated by diabetes?
Elisabeth Mathiesen - CGM in
type 1 patients during pregnancy
new insights
6
17:30-18:00
SESSION 23
PARALLEL INDUSTRY
7
SATURDAY FEBRUARY 21, 2015
Hall I
Hall II
Hall III
Hall IV
SESSION 24 – PARALLEL
SAFETY OF MEDICAL DEVICES
FOR DIABETES
Chairpersons: David Klonoff and
Tadej Bettelino
SESSION 25 – PARALLEL
TWELVE YEARS OF
COLLABORATIVE
TRANSATLANTIC
RESEARCH ON ARTIFICIAL
PANCREAS; FIRST
PRESENTATIONS OF THE
2014 STUDIES.
Chairpersons: Bruce
Buckingham, Boris
Kovatchev, Marc Breton and
Eric Renard
Eric Renard (Montpellier) Introduction
Patrick Keith-Hynes (UVA)
- Technology Overview
Sue Brown (UVA) – Study
1 (NIH Phase 5)
Hans de Vries (AMC) Study 2 (AP@Home)
Claudio Cobelli (PAD) –
Study 3 (JDRF-3)
Bruce Buckingham
(Stanford) - Study 4
(Helmsley)
Stacey Anderson (UVA) Study 5 (NIH DP3)
Boris Kovatchev (UVA) –
Conclusion
Presenters' panel - Q&A
SESSION 26 –
PARALLEL
ORAL PRESENTATIONS
SESSION 27 –
PARALLEL
ORAL PRESENTATIONS
08:30-10:00
Andrew Boulton – Medical device
safety – the EASD-EU view
David Klonoff – The need for
post market surveillance of
cleared blood glucose monitors
Desmond Schatz - Medical
Devices: The ADA View
10:00-10:30
COFFEE BREAK
8
PARALLEL
ORAL PRESENTATIONS
10:30-12:00
SESSION 29 – PARALLEL
AP DATA CLUB
Chairpersons: Eric Renard
and Bruce Buckingham
SESSION 28 – PARALLEL
DIABETES AND MOBILE
APPS
Chairpersons: Michael Riddell
and
SESSION 30 – PARALLEL
ARIA: NOTHING NEW
UNDER THE SUN?
Chairpersons: Hans De Vries
and Lutz Heinemann
Michael Riddell - Apps in
Diabetes and sport.
Neal Kaufman - Technologyenabled interventions: the
future is now
Ashleigh Walker – keep track
with Apps
Eric Zijlstra -Inhaled insulin
reloaded: Impact of Afrezza
Leona Plum - Mörschel Oral insulin: what is going on?
Andreas Liebl Intraperitoneal insulin delivery
through implanted port
Pauline Schaepelynck Implantable insulin pumps
SESSION 31 – PLENARY
12:00-12:30
Stephanie Amiel –
Neuroimaging in insulin
resistance
CLOSING REMARKS
12:30-12:40
12:40-13:00
FAREWELL – Moshe Phillip
FAREWELL Refreshments